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We would like to thank Sertoglu et al. for their interest in our recent article [1]. Here are the 
responses to their comments. 
Regarding to their first comment, we would like to point out that all of our patients had total and 
differential white blood cell counts within the normal range as defined by our laboratory. 
Although it might be true that using a specific WBC range as an exclusion criterion may reduce 
biases, it is currently unclear what specific range should be chosen or taken. Furthermore, adding 
yet another exclusion criterion would further limit the clinical utility of preoperative neutrophil-
to-lymphocyte ratio (NLR) in cN0 PTC as fewer consecutive patients would be eligible. As 
correctly pointed out, there are many factors such as individual laboratory, instruments and 
measurement methods that may could potentially affect the accuracy and reliability of 
preoperative NLR and that was the reason why all blood counts were taken around the same time 
of the day one day before the actual thyroidectomy and were analyzed in the same laboratory 
using the same whole blood analyzer within a few hours of collection.  
Regarding to their second comment, our chosen cut-off values for NLR actually represented the 
tertiles (i.e. values which divided the cohort into lower one-third (0-33.3%), middle one-third 
(33.4-66.7%) and upper one-third (66.8 – 100%)). The main purpose was to have a roughly equal 
number of patients within each group for comparison. Another advantage of having three groups 
(instead of two using say, the median) was the ability to observe any interesting trend with 
higher tertiles. Although the receiver-operating characteristic analysis is a great way of 
determining an optimal cut-off for test sensitivity and specificity, this was not our primary aim of 
our analysis. We did compare our overall NLR with that of the two previous studies [2,3] and 
they appeared similar in actual value. 
Regarding to the last comment, although we agree that it might be interesting to further study the 
role of other inflammatory markers such as CRP, ESR, IL-6 in papillary thyroid carcinoma 
(PTC), given the findings of the present study, we are less optimistic on their prognostic 
potential. In our opinion, unlike other non-thyroidal cancers like lungs, breasts and kidneys, PTC 
induces very limited systemic inflammation. This is supported by our data showing that the NLR 
between those with a benign goiter and with a clinically-nodal positive PTC was not significantly 
different (2.80 ± 1.77 vs. 2.74 ± 2.32, p=0.951). Perhaps, this might be why even PTC patients 
presenting with distant metastases can remain relatively asymptomatic and do extremely well for 
a long-period [4]. 
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